US drugmaker Pfizer and German partner BioNTech SE said on Friday their Omicron-tailored shot targeting the BA.4/5 subvariants produced a strong antibody response in older adults than the original shot after one month. In October, the companies had released data which showed the vaccine produced higher virus-neutralizing antibodies in humans after a week, but did not disclose the levels of …
Read More »PFIZER/BIONTECH OMICRON VACCINE SHOWS STRONG RESPONSE
November 6, 2022